CelLBxHealth plc (FRA:DWV)

Market Cap	11.42M +47.2%
Revenue (ttm)	1.34M -56.1%
Net Income	-15.03M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,000
Open	0.0095
Previous Close	0.0095
Day's Range	0.0095 - 0.0100
52-Week Range	0.0005 - 0.0465
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 15, 2026

About CelLBxHealth

CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix platform, emables real-time multiomic insights from blood. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal circulating tumour cells; and CellKeep Slide, a CTC harvesting technology. In addition, the company o...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1994
• Employees: 114
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: DWV

Financial Performance

In 2025, CelLBxHealth's revenue was 1.35 million, a decrease of -52.80% compared to the previous year's 2.86 million. Losses were -19.51 million, 37.1% more than in 2024.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 13, 2026

Data Sources Report a data error